Literature DB >> 26053663

Selenoprotein P influences colitis-induced tumorigenesis by mediating stemness and oxidative damage.

Caitlyn W Barrett, Vishruth K Reddy, Sarah P Short, Amy K Motley, Mary K Lintel, Amber M Bradley, Tanner Freeman, Jefferson Vallance, Wei Ning, Bobak Parang, Shenika V Poindexter, Barbara Fingleton, Xi Chen, Mary K Washington, Keith T Wilson, Noah F Shroyer, Kristina E Hill, Raymond F Burk, Christopher S Williams.   

Abstract

Patients with inflammatory bowel disease are at increased risk for colon cancer due to augmented oxidative stress. These patients also have compromised antioxidant defenses as the result of nutritional deficiencies. The micronutrient selenium is essential for selenoprotein production and is transported from the liver to target tissues via selenoprotein P (SEPP1). Target tissues also produce SEPP1, which is thought to possess an endogenous antioxidant function. Here, we have shown that mice with Sepp1 haploinsufficiency or mutations that disrupt either the selenium transport or the enzymatic domain of SEPP1 exhibit increased colitis-associated carcinogenesis as the result of increased genomic instability and promotion of a protumorigenic microenvironment. Reduced SEPP1 function markedly increased M2-polarized macrophages, indicating a role for SEPP1 in macrophage polarization and immune function. Furthermore, compared with partial loss, complete loss of SEPP1 substantially reduced tumor burden, in part due to increased apoptosis. Using intestinal organoid cultures, we found that, compared with those from WT animals, Sepp1-null cultures display increased stem cell characteristics that are coupled with increased ROS production, DNA damage, proliferation, decreased cell survival, and modulation of WNT signaling in response to H2O2-mediated oxidative stress. Together, these data demonstrate that SEPP1 influences inflammatory tumorigenesis by affecting genomic stability, the inflammatory microenvironment, and epithelial stem cell functions.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26053663      PMCID: PMC4563672          DOI: 10.1172/JCI76099

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  76 in total

1.  Tumor-conditioned macrophages secrete migration-stimulating factor: a new marker for M2-polarization, influencing tumor cell motility.

Authors:  Graziella Solinas; Silvia Schiarea; Manuela Liguori; Marco Fabbri; Samantha Pesce; Luca Zammataro; Fabio Pasqualini; Manuela Nebuloni; Chiara Chiabrando; Alberto Mantovani; Paola Allavena
Journal:  J Immunol       Date:  2010-06-07       Impact factor: 5.422

2.  Role of selenium-containing proteins in T-cell and macrophage function.

Authors:  Bradley A Carlson; Min-Hyuk Yoo; Rajeev K Shrimali; Robert Irons; Vadim N Gladyshev; Dolph L Hatfield; Jin Mo Park
Journal:  Proc Nutr Soc       Date:  2010-06-25       Impact factor: 6.297

3.  Proinflammatory cytokines down-regulate intestinal selenoprotein P biosynthesis via NOS2 induction.

Authors:  Bodo Speckmann; Antonio Pinto; Meike Winter; Irmgard Förster; Helmut Sies; Holger Steinbrenner
Journal:  Free Radic Biol Med       Date:  2010-06-09       Impact factor: 7.376

4.  Effects of selenium status and polymorphisms in selenoprotein genes on prostate cancer risk in a prospective study of European men.

Authors:  Astrid Steinbrecher; Catherine Méplan; John Hesketh; Lutz Schomburg; Tobias Endermann; Eugène Jansen; Björn Akesson; Sabine Rohrmann; Jakob Linseisen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-09-17       Impact factor: 4.254

Review 5.  Inflammatory bowel disease.

Authors:  Clara Abraham; Judy H Cho
Journal:  N Engl J Med       Date:  2009-11-19       Impact factor: 91.245

6.  Relative abundance of selenoprotein P isoforms in human plasma depends on genotype, se intake, and cancer status.

Authors:  Catherine Méplan; Fergus Nicol; Brian T Burtle; Lynne K Crosley; John R Arthur; John C Mathers; John E Hesketh
Journal:  Antioxid Redox Signal       Date:  2009-11       Impact factor: 8.401

7.  Four selenoproteins, protein biosynthesis, and Wnt signalling are particularly sensitive to limited selenium intake in mouse colon.

Authors:  Anna Kipp; Antje Banning; Evert M van Schothorst; Catherine Méplan; Lutz Schomburg; Chris Evelo; Susan Coort; Stan Gaj; Jaap Keijer; John Hesketh; Regina Brigelius-Flohé
Journal:  Mol Nutr Food Res       Date:  2009-12       Impact factor: 5.914

8.  Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer.

Authors:  J Joshua Smith; Natasha G Deane; Fei Wu; Nipun B Merchant; Bing Zhang; Aixiang Jiang; Pengcheng Lu; J Chad Johnson; Carl Schmidt; Christina E Bailey; Steven Eschrich; Christian Kis; Shawn Levy; M Kay Washington; Martin J Heslin; Robert J Coffey; Timothy J Yeatman; Yu Shyr; R Daniel Beauchamp
Journal:  Gastroenterology       Date:  2009-11-13       Impact factor: 22.682

9.  Selenoproteins regulate macrophage invasiveness and extracellular matrix-related gene expression.

Authors:  Bradley A Carlson; Min-Hyuk Yoo; Yasuyo Sano; Aniruddha Sengupta; Jin Young Kim; Robert Irons; Vadim N Gladyshev; Dolph L Hatfield; Jin Mo Park
Journal:  BMC Immunol       Date:  2009-10-28       Impact factor: 3.615

10.  TopHat: discovering splice junctions with RNA-Seq.

Authors:  Cole Trapnell; Lior Pachter; Steven L Salzberg
Journal:  Bioinformatics       Date:  2009-03-16       Impact factor: 6.937

View more
  36 in total

Review 1.  Selenoproteins in colon cancer.

Authors:  Kristin M Peters; Bradley A Carlson; Vadim N Gladyshev; Petra A Tsuji
Journal:  Free Radic Biol Med       Date:  2018-05-22       Impact factor: 7.376

Review 2.  Roles for selenium and selenoprotein P in the development, progression, and prevention of intestinal disease.

Authors:  Sarah P Short; Jennifer M Pilat; Christopher S Williams
Journal:  Free Radic Biol Med       Date:  2018-05-17       Impact factor: 7.376

3.  Innate-like functions of natural killer T cell subsets result from highly divergent gene programs.

Authors:  Isaac Engel; Grégory Seumois; Lukas Chavez; Daniela Samaniego-Castruita; Brandie White; Ashu Chawla; Dennis Mock; Pandurangan Vijayanand; Mitchell Kronenberg
Journal:  Nat Immunol       Date:  2016-04-18       Impact factor: 25.606

4.  BVES Regulates Intestinal Stem Cell Programs and Intestinal Crypt Viability after Radiation.

Authors:  Vishruth K Reddy; Sarah P Short; Caitlyn W Barrett; Mukul K Mittal; Cody E Keating; Joshua J Thompson; Elizabeth I Harris; Frank Revetta; David M Bader; Thomas Brand; M Kay Washington; Christopher S Williams
Journal:  Stem Cells       Date:  2016-03-15       Impact factor: 6.277

Review 5.  Parasites, nutrition, immune responses and biology of metabolic tissues.

Authors:  T Shea-Donohue; B Qin; A Smith
Journal:  Parasite Immunol       Date:  2017-03-22       Impact factor: 2.280

Review 6.  Selenoproteins and oxidative stress-induced inflammatory tumorigenesis in the gut.

Authors:  Caitlyn W Barrett; Sarah P Short; Christopher S Williams
Journal:  Cell Mol Life Sci       Date:  2016-08-25       Impact factor: 9.261

7.  Mutation accumulation in cancer genes relates to nonoptimal outcome in chronic myeloid leukemia.

Authors:  Shady Adnan Awad; Matti Kankainen; Teija Ojala; Perttu Koskenvesa; Samuli Eldfors; Bishwa Ghimire; Ashwini Kumar; Soili Kytölä; Mahmoud M Kamel; Caroline A Heckman; Kimmo Porkka; Satu Mustjoki
Journal:  Blood Adv       Date:  2020-02-11

Review 8.  Selenoproteins in Tumorigenesis and Cancer Progression.

Authors:  Sarah P Short; Christopher S Williams
Journal:  Adv Cancer Res       Date:  2017       Impact factor: 6.242

Review 9.  Prevention and treatment of cancers by immune modulating nutrients.

Authors:  Naveena B Janakiram; Altaf Mohammed; Venkateshwar Madka; Gaurav Kumar; Chinthalapally V Rao
Journal:  Mol Nutr Food Res       Date:  2016-03-09       Impact factor: 5.914

10.  Selenoprotein P in colitis-associated carcinoma.

Authors:  Sarah P Short; Caitlyn Whitten-Barrett; Christopher S Williams
Journal:  Mol Cell Oncol       Date:  2015-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.